Skip to main content
. 2015 Jul 22;7(3):2329–2342. doi: 10.18632/oncotarget.4919

Table 1. Summary of in vitro MIA, SRB & PI data for CCT245737.

Cells MIA
(μM)
GI50
(μM)
Genotoxic
Agent
Combination GI50
(μM)
Potentiation Index
(PI)
HT29 0.030±0.012 (n = 6) 0.70±0.29 (n = 6) SN38 0.39±0.061 (n = 3) 1.8±0.31* (n = 3)
Gem 0.09±0.023 (n = 6) 7.9±2.1*** (n = 6)
SW620 0.22±0.047 (n = 3) 5.4±1.4 (n = 5) SN38 1.8±0.57 (n = 4) 3.1±1.5* (n = 4)
Gem 0.33±0.064 (n = 7) 17±3.4*** (n = 7)
MiaPaCa-2 0.063±0.011 (n = 3) 1.3±0.40 (n = 3) SN38 0.43±0.062 (n = 3) 3.1±0.43* (n = 3)
Gem 0.066±0.025 (n = 3) 23±9.6 (n = 3)
Calu6 0.084±0.0070 (n = 3) 0.41±0.059 (n = 3) SN38 0.32±0.021 (n = 3) 1.3±0.084* (n = 3)
Gem 0.046±0.0069 (n = 3) 9.1±1.5* (n = 3)

Mitosis induction assay (MIA IC50) results and cytotoxicity (GI50) values were determined as described in Material and Methods. Potentiation index (PI) is the ratio of GI50 / Combination GI50. Potentiation index (PI) values.1 indicate potentiation of the genotoxic drug. Values are mean±SD of n independent determinations.

*

Statistical significance: P < 0.05

**

P < 0.01

***

P < 0.001.